Annual Operating Expenses
$885.10 M
+$80.10 M+9.95%
31 December 2023
Summary:
United Therapeutics annual total operating expenses is currently $885.10 million, with the most recent change of +$80.10 million (+9.95%) on 31 December 2023. During the last 3 years, it has risen by +$103.50 million (+13.24%). UTHR annual operating expenses is now -41.72% below its all-time high of $1.52 billion, reached on 31 December 2019.UTHR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$257.60 M
-$59.60 M-18.79%
30 September 2024
Summary:
United Therapeutics quarterly total operating expenses is currently $257.60 million, with the most recent change of -$59.60 million (-18.79%) on 30 September 2024. Over the past year, it has increased by +$45.30 million (+21.34%). UTHR quarterly operating expenses is now -73.96% below its all-time high of $989.40 million, reached on 31 March 2019.UTHR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.9% | +21.3% |
| 3 y3 years | +13.2% | +36.8% |
| 5 y5 years | +41.9% | +39.2% |
UTHR Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -12.1% | +13.2% | -18.8% | +74.0% |
| 5 y | 5 years | -41.7% | +41.9% | -38.8% | +90.8% |
| alltime | all time | -41.7% | +6505.2% | -74.0% | +3445.4% |
United Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $257.60 M(-18.8%) |
| June 2024 | - | $317.20 M(+27.6%) |
| Mar 2024 | - | $248.50 M(-12.4%) |
| Dec 2023 | $885.10 M(+10.0%) | $283.60 M(+33.6%) |
| Sept 2023 | - | $212.30 M(-3.1%) |
| June 2023 | - | $219.00 M(+28.7%) |
| Mar 2023 | - | $170.20 M(-33.8%) |
| Dec 2022 | $805.00 M(-20.1%) | $257.10 M(+56.3%) |
| Sept 2022 | - | $164.50 M(-30.1%) |
| June 2022 | - | $235.40 M(+59.1%) |
| Mar 2022 | - | $148.00 M(-29.8%) |
| Dec 2021 | $1.01 B(+28.9%) | $210.80 M(+11.9%) |
| Sept 2021 | - | $188.30 M(+0.6%) |
| June 2021 | - | $187.10 M(-55.5%) |
| Mar 2021 | - | $420.90 M(+47.8%) |
| Dec 2020 | $781.60 M(-48.5%) | $284.80 M(+111.0%) |
| Sept 2020 | - | $135.00 M(-31.0%) |
| June 2020 | - | $195.60 M(+17.7%) |
| Mar 2020 | - | $166.20 M(-24.0%) |
| Dec 2019 | $1.52 B(+143.5%) | $218.80 M(+18.2%) |
| Sept 2019 | - | $185.10 M(+47.5%) |
| June 2019 | - | $125.50 M(-87.3%) |
| Mar 2019 | - | $989.40 M(+353.9%) |
| Dec 2018 | $623.70 M(+4.9%) | $218.00 M(+3.2%) |
| Sept 2018 | - | $211.20 M(+27.7%) |
| June 2018 | - | $165.40 M(+468.4%) |
| Mar 2018 | - | $29.10 M(-89.3%) |
| Dec 2017 | $594.70 M(+28.1%) | $272.70 M(+166.8%) |
| Sept 2017 | - | $102.20 M(-19.7%) |
| June 2017 | - | $127.20 M(+37.4%) |
| Mar 2017 | - | $92.60 M(-55.1%) |
| Dec 2016 | $464.40 M(-33.4%) | $206.40 M(+41.4%) |
| Sept 2016 | - | $146.00 M(+35.9%) |
| June 2016 | - | $107.40 M(+2234.8%) |
| Mar 2016 | - | $4.60 M(-98.0%) |
| Dec 2015 | $697.80 M(+11.9%) | $224.60 M(-3016.9%) |
| Sept 2015 | - | -$7.70 M(-104.8%) |
| June 2015 | - | $159.40 M(-50.4%) |
| Mar 2015 | - | $321.50 M(+111.5%) |
| Dec 2014 | $623.80 M(-10.0%) | $151.98 M(-52.7%) |
| Sept 2014 | - | $321.38 M(+198.2%) |
| June 2014 | - | $107.77 M(+152.6%) |
| Mar 2014 | - | $42.66 M(-84.7%) |
| Dec 2013 | $693.36 M(+84.8%) | $278.73 M(+67.0%) |
| Sept 2013 | - | $166.86 M(+32.4%) |
| June 2013 | - | $125.98 M(+3.4%) |
| Mar 2013 | - | $121.79 M(+57.0%) |
| Dec 2012 | $375.13 M(+11.5%) | $77.55 M(-42.0%) |
| Sept 2012 | - | $133.78 M(+48.1%) |
| June 2012 | - | $90.36 M(+23.0%) |
| Mar 2012 | - | $73.45 M(-30.9%) |
| Dec 2011 | $336.50 M | $106.34 M(+39.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $76.09 M(+58.2%) |
| June 2011 | - | $48.10 M(-54.6%) |
| Mar 2011 | - | $105.97 M(-18.4%) |
| Dec 2010 | $353.91 M(+18.6%) | $129.82 M(+51.1%) |
| Sept 2010 | - | $85.93 M(+99.9%) |
| June 2010 | - | $42.98 M(-47.4%) |
| Mar 2010 | - | $81.75 M(-16.2%) |
| Dec 2009 | $298.53 M(-10.5%) | $97.61 M(+34.2%) |
| Sept 2009 | - | $72.72 M(-6.8%) |
| June 2009 | - | $78.02 M(+55.5%) |
| Mar 2009 | - | $50.18 M(-75.1%) |
| Dec 2008 | $333.49 M(+82.9%) | $201.62 M(+309.5%) |
| Sept 2008 | - | $49.23 M(+16.6%) |
| June 2008 | - | $42.23 M(+4.5%) |
| Mar 2008 | - | $40.41 M(-34.8%) |
| Dec 2007 | $182.38 M(+60.5%) | $61.94 M(+60.0%) |
| Sept 2007 | - | $38.72 M(+0.7%) |
| June 2007 | - | $38.44 M(-11.2%) |
| Mar 2007 | - | $43.28 M(+15.3%) |
| Dec 2006 | $113.62 M(+87.2%) | $37.52 M(+51.2%) |
| Sept 2006 | - | $24.81 M(+1.3%) |
| June 2006 | - | $24.48 M(-8.6%) |
| Mar 2006 | - | $26.80 M(+66.1%) |
| Dec 2005 | $60.71 M(+16.5%) | $16.13 M(+7.2%) |
| Sept 2005 | - | $15.04 M(-4.3%) |
| June 2005 | - | $15.72 M(+13.8%) |
| Mar 2005 | - | $13.81 M(+5.9%) |
| Dec 2004 | $52.13 M(-10.2%) | $13.05 M(+7.5%) |
| Sept 2004 | - | $12.14 M(-4.3%) |
| June 2004 | - | $12.69 M(-11.1%) |
| Mar 2004 | - | $14.26 M(-9.9%) |
| Dec 2003 | $58.08 M(+36.1%) | $15.83 M(+5.4%) |
| Sept 2003 | - | $15.03 M(+1.6%) |
| June 2003 | - | $14.79 M(+18.8%) |
| Mar 2003 | - | $12.44 M(-8.8%) |
| Dec 2002 | $42.67 M(-13.9%) | $13.64 M(+31.3%) |
| Sept 2002 | - | $10.39 M(-5.8%) |
| June 2002 | - | $11.03 M(+44.9%) |
| Mar 2002 | - | $7.61 M(-26.7%) |
| Dec 2001 | $49.53 M(-39.5%) | $10.38 M(-15.9%) |
| Sept 2001 | - | $12.35 M(-8.9%) |
| June 2001 | - | $13.56 M(+2.5%) |
| Mar 2001 | - | $13.23 M(-57.5%) |
| Dec 2000 | $81.84 M(+137.9%) | $31.15 M(+194.5%) |
| Sept 2000 | - | $10.57 M(-65.5%) |
| June 2000 | - | $30.67 M(+224.4%) |
| Mar 2000 | - | $9.45 M(+13.9%) |
| Dec 1999 | $34.40 M(+156.7%) | $8.30 M(+15.3%) |
| Sept 1999 | - | $7.20 M(+14.3%) |
| June 1999 | - | $6.30 M(-49.2%) |
| Mar 1999 | - | $12.40 M |
| Dec 1998 | $13.40 M | - |
FAQ
- What is United Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for United Therapeutics?
- What is United Therapeutics annual operating expenses year-on-year change?
- What is United Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for United Therapeutics?
- What is United Therapeutics quarterly operating expenses year-on-year change?
What is United Therapeutics annual total operating expenses?
The current annual operating expenses of UTHR is $885.10 M
What is the all time high annual operating expenses for United Therapeutics?
United Therapeutics all-time high annual total operating expenses is $1.52 B
What is United Therapeutics annual operating expenses year-on-year change?
Over the past year, UTHR annual total operating expenses has changed by +$80.10 M (+9.95%)
What is United Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of UTHR is $257.60 M
What is the all time high quarterly operating expenses for United Therapeutics?
United Therapeutics all-time high quarterly total operating expenses is $989.40 M
What is United Therapeutics quarterly operating expenses year-on-year change?
Over the past year, UTHR quarterly total operating expenses has changed by +$45.30 M (+21.34%)